Your browser doesn't support javascript.
loading
Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer.
Yam, Clinton; Yen, Er-Yen; Chang, Jeffrey T; Bassett, Roland L; Alatrash, Gheath; Garber, Haven; Huo, Lei; Yang, Fei; Philips, Anne V; Ding, Qing-Qing; Lim, Bora; Ueno, Naoto T; Kannan, Kasthuri; Sun, Xiangjie; Sun, Baohua; Parra Cuentas, Edwin Roger; Symmans, William Fraser; White, Jason B; Ravenberg, Elizabeth; Seth, Sahil; Guerriero, Jennifer L; Rauch, Gaiane M; Damodaran, Senthil; Litton, Jennifer K; Wargo, Jennifer A; Hortobagyi, Gabriel N; Futreal, Andrew; Wistuba, Ignacio I; Sun, Ryan; Moulder, Stacy L; Mittendorf, Elizabeth A.
Afiliação
  • Yam C; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Yen EY; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Chang JT; Department of Integrative Biology and Pharmacology, The University of Texas Health Science Center at Houston, Houston, Texas.
  • Bassett RL; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Alatrash G; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Garber H; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Huo L; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Yang F; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Philips AV; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ding QQ; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Lim B; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ueno NT; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Kannan K; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Sun X; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Sun B; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Parra Cuentas ER; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Symmans WF; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • White JB; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ravenberg E; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Seth S; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Guerriero JL; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts.
  • Rauch GM; Breast Oncology Program, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts.
  • Damodaran S; Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Litton JK; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wargo JA; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Hortobagyi GN; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Futreal A; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wistuba II; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Sun R; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Moulder SL; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Mittendorf EA; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Clin Cancer Res ; 27(19): 5365-5375, 2021 10 01.
Article em En | MEDLINE | ID: mdl-34253579
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias de Mama Triplo Negativas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias de Mama Triplo Negativas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article